Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Wu
    Wu
  10. Wolden
    Wolden

Groups

  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)
  7. Center for Hematologic Malignancies (1674)
  8. Hematologic Malignancies, Division of (1609)
  9. Gynecology Disease Management Team (1425)
  10. Sloan Kettering Institute Faculty (1413)
Search Within
Formats
  1. Journal Article (7387)
  2. Meeting Abstract (4694)
  3. Review (616)
  4. Book Section (538)
  5. Editorial (250)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (240)
  2. 2024 (784)
  3. 2023 (762)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2610)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (967)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (524)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13855)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The implementation of an electronic symptom management system to monitor postoperative pain in gynecologic oncology surgery patients: A multicenter evaluation
    Meeting Abstract

    Bradford, L.; Nguyen, L.; Wong, S.; Jenkins, H. H.; Osarogiagbon, R.; Davis, M.; Dizon, D.; Hassett, M.; Schrag, D.; Wright, A.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Use of ChatGPT for management recommendations in advanced ovarian cancer
    Meeting Abstract

    Finch, L.; Broach, V.; Feinberg, J.; Roche, K. L.; Gardner, G.; Sonoda, Y.; Abu-Rustum, N.; Chi, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Voices of women with low-grade serous ovarian cancer: Results from a multinational survey
    Meeting Abstract

    Sun, C.; Andrews, N.; Ludemann, J.; Larsen, E.; MacKay, C.; de Fazio, A.; Gaillard, S.; Gourley, C.; Carey, M.; Fader, A.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Trends and disparities in the provision of salpingectomy for surgical sterilization: The underbelly of coding, billing, and reimbursement
    Meeting Abstract

    Hazimeh, D.; Krishnamoorthi, M.; Yanek, L.; Beavis, A.; Fader, A.; Davis, J.; Roche, K. L.; Wethington, S.; Stone, R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer
    Meeting Abstract

    Sullivan, M.; Graves, S.; Adkoli, A.; Zhou, Q.; Iasonos, A.; Ellenson, L.; Chi, D.; O'Cearbhaill, R.; Weigelt, B.; Grisham, R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study
    Meeting Abstract

    Dockery, L.; Slomovitz, B.; Priebe, A.; Green, A.; Mathews, C.; Musa, F.; Puechl, A.; Birrer, M.; Spirtos, N.; Ding, L.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • UPLIFT (ENGOT-ov67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin, a NaPi2b-directed dolaflexin antibody-drug conjugate, in platinum-resistant ovarian cancer
    Meeting Abstract

    Richardson, D.; Iyer, G.; Schmid, A.; Palma, N.; Navarro, W.; Ahnert, J. R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Meeting Abstract

    Pothuri, B.; Valabrega, G.; Oaknin, A.; Graybill, W.; Sánchez, A. B.; McCormick, C.; Baurain, J. F.; Tinker, A.; Denys, H.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase II, open-label, multicenter, basket study of the ATR kinase inhibitor ART0380 administered orally as monotherapy to patients with biologically selected advanced or metastatic solid tumors (ARTIST)
    Meeting Abstract

    Aghajanian, C.; Washington, C.; Moore, K.; Krivak, T.; Mathews, C.; Philip, T.; Konecny, G.; Fleming, G.; Martin, N.; Smith, G.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A randomized, double-blind, phase II study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib versus pembrolizumab plus lenvatinib among patients with previously-treated mismatch repair proficient advanced endometrial cancer
    Meeting Abstract

    Girda, E.; Makker, V.; Marth, C.; Van Gorp, T.; Mirza, M.; Shapira-Frommer, R.; Suttner, L.; Groisberg, R.; Jin, F.; O'Malley, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save